1. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
2. Molina JM , Bercot, Beatrice , Assoumou L , Michele, Algarte-Genin , Rubenstein, Emma , Pialoux, Gilles , et al. ANRS 174 DOXYVAC: AN OPEN-LABEL RANDOMIZED TRIAL TO PREVENT STIs IN MSM ON PrEP - CROI Conference. In 2023 [cited 2023 Sep 8]. Available from: https://www.croiconference.org/abstract/anrs-174-doxyvac-an-open-label-randomized-trial-to-prevent-stis-in-msm-on-prep/
3. California Department of Public Health. Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Bacterial Sexually Transmitted Infections (STIs). State of California Health and Human Services Agency. 2023 Apr 28;
4. San Francisco Department of Public Health. Health Update: Doxycycline Post-Exposure Prophylaxis Reduces Incidence of Sexually Transmitted Infections. SFDPH Population Health Division. 2022 Oct 20;
5. Mortimer TD , Grad YH . A Genomic Perspective on the Near-term Impact of Doxycycline Post-exposure Prophylaxis on Neisseria gonorrhoeae Antimicrobial Resistance. Clin Infect Dis. 2023 May 4;ciad279.